INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![450_300-img002]( "Should Sponsors Provide Source Document Templates?")
Should Sponsors Provide Source Document Templates?Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.
-
![GettyImages-891264822 planning, meeting]( "Equitable Access To Clinical Trials & The Trial Modernization Act")
Equitable Access To Clinical Trials & The Trial Modernization ActHow are the Equitable Access to Clinical Trials (EACT) initiative and Clinical Trial Modernization Act (CTMA) being used to improve clinical trial inclusivity by addressing financial barriers?
-
![Built for sites to benefit all]( "Built For Sites To Benefit All")
Built For Sites To Benefit AllThis one-minute video highlights the benefits of One Home for Sites. Join the movement to increase clinical trial capacity, because patients are waiting.
-
![Better rtsm ux]( "Better RTSM UX = Happy Clinical Trial Sites")
Better RTSM UX = Happy Clinical Trial SitesSee how thoughtful RTSM design can ease site workloads, reduce support needs, and elevate staff satisfaction. Learn why intuitive user experiences quietly strengthen trial execution.
-
Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call3/21/2025
Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.
-
Developing Community-Based And Trial-Naïve Sites: The Real ROI9/9/2025
Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.
-
Choose eClinical Software Built for the Full Study Lifecycle, Not Just Startup3/25/2026
This clip explores why choosing an RTSM partner requires more than fast startup timelines, highlighting how long‑term flexibility and operational durability matter far more once a study is underway.
-
Transparent Pricing In Bioanalysis: A Feature, Not A Bonus3/9/2026
Unclear CRO pricing leaves small biotechs vulnerable to budget swings. Transparent, itemized costs cut financial risk, sharpen planning, and build trust by setting expectations from the start.
-
Considerations For Subcutaneous, Intramuscular Formulation Development8/7/2025
Explore the changing landscape of parenteral delivery, considering the pros and cons of intravenous, subcutaneous, and intramuscular formulations, and how new technologies are reshaping drug delivery.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-1288978528 Scientist Using Microscope In Lab]( "Drug Development Experience For Biotechs")
Leverage our extensive expertise across over 120 therapeutic indications to drive your success.
-
![Adult woman sits in waiting room-GettyImages-1372189785]( "Support For Clinical Trial Participants")
Clinical trials are how new treatments move from the lab to the people who need them most. By joining a study, you’re not only accessing potential new therapies—you’re helping advance medicine for future generations.
-
![Autoinjector-Insulin-Pen-Delivery-Device-GettyImages- 1086688132]( "Autoinjector, Pen, And Prefilled Syringe Capabilities")
Flexible, scalable capabilities for autoinjectors, pens, and prefilled syringes — ranging from manual to fully automated — streamlining and simplifying your biologic drug development supply chain.
-
![GettyImages-691189734-pill-analysis-microscope-gloved-hand]( "Human ADME Studies: Human Metabolism Data For Regulatory Submission")
Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.
-
![gettty-2155090853-data]( "Lock Into Your Go-To Data Strategy")
Explore data solutions for every clinical study - whether you are engaging our comprehensive CRO services or require specific, functional solutions to support your project.
